EX-FILING FEES 7 tm2219399d2_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

 

Calculation of Filing Fee Tables

 

Form F-3

(Form Type)

 

Calliditas Therapeutics AB

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

  Security Type  Security Class Title  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
   Proposed
Maximum
Offering
Price Per
Unit
   Maximum
Aggregate
Offering Price
   Fee Rate   Amount of
Registration
Fee
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
effective
date
  Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
 
Newly Registered Securities 
  Equity  Common shares, quota value SEK 0.04 per share  Rule 457(o)  (1)  (2)    (3)   0.0000927             
   Debt  Debt Securities  Rule 457(o)  (1)  (2)    (3)   0.0000927                 
   Other  Warrants  Rule 457(o)  (1)  (2)    (3)   0.0000927                 
   Unallocated
(Universal) Shelf
     Rule 457(o)  (1)  (2)  $ 200,000,000.00    0.0000927   $18,540.00             
Carry Forward Securities 
Carry Forward Securities                                 
   Total Offering Amounts       $ 200,000,000.00        $18,540.00             
   Total Fees Previously Paid                                
   Total Fee Offsets                                
   Net Fee Due                  $18,540.00             

 

(1) The amount to be registered consists of up to $200,000,000.00 of an indeterminate amount of common shares, which may be sold in the form of American Depositary Shares, or ADSs, such indeterminate principal amount of debt securities and such indeterminate number of warrants to purchase common shares, common shares in the form of ADSs or debt securities. ADSs issuable upon deposit of the common shares registered hereby have been registered under a separate registration statement on Form F-6 (File No. 333-238726). Each ADS represents the right to receive two common shares. If any debt securities are issued at an original issue discount, then the principal amount of such debt securities shall be in such greater amount as shall result in an aggregate initial offering price not to exceed $200,000,000.00.  Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The securities registered also include such indeterminate number of common shares, common shares in the form of ADSs and debt securities as may be issued upon conversion of or exchange for debt securities that provide for conversion or exchanges, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the shares being registered hereunder include such indeterminate number of common shares as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2) The proposed maximum aggregate offering price per unit will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security.
(3) Estimated solely for purposes of computing the registration fee pursuant to Rule 457(o) under the Securities Act. In no event will the aggregate offering price of all securities sold by the registrant from time to time pursuant to this registration statement exceed $200,000,000.00. No separate consideration will be received for (i) common shares, or common shares in the form of ADSs or (ii) common shares or common shares in the form of ADSs that may be issued upon exercise or conversion of warrants or debt securities registered hereby, as the case may be.